Visium Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Visium Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,923	Closed	-$436K	–	890
2015 Q2	$436K	Buy	+3,923	New	+$423K	0.01%	687
2014 Q1	–	Sell	-35,000	Closed	-$838K	–	855
2013 Q4	$838K	Sell	35,000 -600	-2%	-$13.7K	0.02%	478
2013 Q3	$995K	Buy	+35,600	New	+$983K	0.02%	430

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

FV2GP

Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Visium Asset Management's AGIO Position: Q3 2015 in Review

Visium Asset Management sold out of Agios Pharmaceuticals (AGIO) in Q3 2015, closing a stake of 3,923 shares — an estimated $436K sold.

Visium Asset Management first reported a position in AGIO in Q3 2013 and held it in 3 quarters. The position peaked at $995K in Q3 2013. 150 funds tracked by Wall St. Rank hold AGIO as of Q3 2015.

Visium Asset Management reported no remaining Agios Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
Visium Asset Management sold 3,923 Agios Pharmaceuticals shares in Q3 2015, an estimated $436K.
Visium Asset Management first reported a position in Agios Pharmaceuticals in Q3 2013 and held it in 3 quarters.
Visium Asset Management's Agios Pharmaceuticals position peaked at $995K in Q3 2013.
150 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2015.

Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.